Harvard Bioscience Net Profit Margin 2010-2024 | HBIO

Harvard Bioscience net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Harvard Bioscience Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-12-31 $0.10B $-0.01B -13.68%
2024-09-30 $0.10B $-0.02B -15.31%
2024-06-30 $0.10B $-0.01B -10.89%
2024-03-31 $0.11B $-0.01B -8.41%
2023-12-31 $0.11B $0.00B -2.68%
2023-09-30 $0.11B $0.00B -2.68%
2023-06-30 $0.11B $-0.01B -4.39%
2023-03-31 $0.11B $0.00B -1.75%
2022-12-31 $0.11B $-0.01B -8.85%
2022-09-30 $0.12B $-0.01B -5.93%
2022-06-30 $0.12B $0.00B -3.31%
2022-03-31 $0.12B $-0.01B -4.96%
2021-12-31 $0.12B 0 0.00%
2021-09-30 $0.12B $0.00B -1.71%
2021-06-30 $0.11B $0.00B -2.70%
2021-03-31 $0.11B $-0.01B -4.76%
2020-12-31 $0.10B $-0.01B -8.82%
2020-09-30 $0.10B $-0.01B -6.86%
2020-06-30 $0.11B $-0.01B -8.57%
2020-03-31 $0.11B $-0.01B -6.25%
2019-12-31 $0.12B $0.00B -3.45%
2019-09-30 $0.12B $0.00B -1.68%
2019-06-30 $0.12B $0.00B 0.83%
2019-03-31 $0.12B 0 0.00%
2018-12-31 $0.12B $0.00B -1.64%
2018-09-30 $0.11B $0.00B -3.64%
2018-06-30 $0.10B $0.00B -4.00%
2018-03-31 $0.09B $0.00B -3.45%
2017-12-31 $0.08B 0 0.00%
2017-09-30 $0.08B $0.00B -2.44%
2017-06-30 $0.09B $0.00B -4.55%
2017-03-31 $0.10B $-0.01B -5.26%
2016-12-31 $0.10B $-0.01B -4.81%
2016-09-30 $0.11B $-0.02B -19.81%
2016-06-30 $0.11B $-0.02B -18.69%
2016-03-31 $0.11B $-0.02B -17.27%
2015-12-31 $0.11B $-0.02B -17.43%
2015-09-30 $0.11B $0.00B -1.80%
2015-06-30 $0.11B 0 0.00%
2015-03-31 $0.11B $0.00B 0.93%
2014-12-31 $0.11B $0.00B 2.78%
2014-09-30 $0.11B $0.00B 1.89%
2014-06-30 $0.11B 0 0.00%
2014-03-31 $0.11B $0.00B -0.95%
2013-12-31 $0.11B $0.00B -1.90%
2013-09-30 $0.11B 0 0.00%
2013-06-30 $0.11B $0.00B 0.94%
2013-03-31 $0.11B $0.00B 1.85%
2012-12-31 $0.11B $0.00B 2.73%
2012-09-30 $0.11B $0.00B 2.70%
2012-06-30 $0.11B $0.00B 2.70%
2012-03-31 $0.11B $0.00B 2.73%
2011-12-31 $0.11B $0.00B 3.70%
2011-09-30 $0.11B $0.01B 4.59%
2011-06-30 $0.11B $0.02B 16.51%
2011-03-31 $0.11B $0.02B 17.59%
2010-12-31 $0.11B $0.02B 17.59%
2010-09-30 $0.11B $0.02B 19.81%
2010-06-30 $0.10B $0.01B 8.91%
2010-03-31 $0.09B $0.01B 7.53%
2009-12-31 $0.09B $0.01B 8.14%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.014B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.685B 15.97
Kewaunee Scientific (KEQU) United States $0.100B 7.00